Impact of pretreatment low-abundance HIV-1 drug-resistant variants on virological failure among HIV-1/TB-co-infected individuals.

Chimukangara, Benjamin; Giandhari, Jennifer; Lessells, Richard; Yende-Zuma, Nonhlanhla; Sartorius, Benn; Samuel, Reshmi; Khanyile, Khulekani S; Stray-Pedersen, Babill; Moodley, Pravi; Metzner, Karin J; Padayatchi, Nesri; Naidoo, Kogieleum; De Oliveira, Tulio

Chimukangara, Benjamin; Giandhari, Jennifer; Lessells, Richard; Yende-Zuma, Nonhlanhla; Sartorius, Benn; Samuel, Reshmi; Khanyile, Khulekani S; Stray-Pedersen, Babill; Moodley, Pravi; Metzner, Karin J; Padayatchi, Nesri; Naidoo, Kogieleum; De Oliveira, Tulio.

Affiliation

Chimukangara B; KwaZulu-Natal Research Innovation and Sequencing Platform (KRISP), College of Health Sciences, University of KwaZulu-Natal, Doris Duke Medical Research Institute, Durban, South Africa.
Giandhari J; Centre for the AIDS Programme of Research in South Africa (CAPRISA), University of KwaZulu-Natal, Durban, South Africa.
Lessells R; Department of Virology, National Health Laboratory Service, University of KwaZulu-Natal, Durban, South Africa.
Yende-Zuma N; KwaZulu-Natal Research Innovation and Sequencing Platform (KRISP), College of Health Sciences, University of KwaZulu-Natal, Doris Duke Medical Research Institute, Durban, South Africa.
Sartorius B; KwaZulu-Natal Research Innovation and Sequencing Platform (KRISP), College of Health Sciences, University of KwaZulu-Natal, Doris Duke Medical Research Institute, Durban, South Africa.
Samuel R; Centre for the AIDS Programme of Research in South Africa (CAPRISA), University of KwaZulu-Natal, Durban, South Africa.
Khanyile KS; South African Medical Research Council (SAMRC), CAPRISA HIV-TB Pathogenesis and Treatment Research Unit, Durban, South Africa.
Stray-Pedersen B; Public Health Medicine, School of Nursing and Public Health, University of KwaZulu-Natal, Durban, South Africa.
Moodley P; Health Metrics Sciences, University of Washington, Seattle, USA.
Metzner KJ; Department of Virology, National Health Laboratory Service, University of KwaZulu-Natal, Durban, South Africa.
Padayatchi N; KwaZulu-Natal Research Innovation and Sequencing Platform (KRISP), College of Health Sciences, University of KwaZulu-Natal, Doris Duke Medical Research Institute, Durban, South Africa.
Naidoo K; Institute of Clinical Medicine, University of Oslo, Oslo University Hospital, Oslo, Norway.
De Oliveira T; Department of Virology, National Health Laboratory Service, University of KwaZulu-Natal, Durban, South Africa.

J Antimicrob Chemother ; 75(11): 3319-3326, 2020 11 01.

Article de En | MEDLINE | ID: mdl-32772079

Sujet(s)

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Préparations pharmaceutiques / Infections à VIH / VIH-1 (Virus de l'Immunodéficience Humaine de type 1) / Agents antiVIH / Co-infection Type d'étude: Observational_studies / Prognostic_studies / Risk_factors_studies Limites: Adult / Humans Langue: En Journal: J Antimicrob Chemother Année: 2020 Type de document: Article Pays d'affiliation: République d'Afrique du Sud

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google